Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow
TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2022 financial results after market close on Tuesday, March 7, 2023.
Related news for (PROF)
- Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
- Profound Medical Annual General and Special Meeting of Shareholders Voting Results
- Profound Medical AUA 2025 Investor Event Agenda
- Save the Date: Profound Medical to Host Investor Event at AUA 2025
- Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results